Abstract 705: Inhibition of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) is a novel therapeutic strategy in B- and T-Acute Lymphoblastic Leukemia (ALL).Ilaria Iacobucci, Giovanni Martinelli, Federica Cattina et al.|Cancer Research|2013Cited by 1
Abstract 4507: New JAK2 heterozygous loss: A role in overall survival in acute myeloid leukemia patientsViviana Guadagnuolo, Giovanni Martinelli, Maria Chiara Fontana et al.|Cancer Research|2016Cited by 0
Abstract 1872: Pharmacological inhibition of WIP1 sensitizes AML cells to MDM2 inhibitorsMaria Chiara Fontana, Giovanni Martinelli, Jacopo Nanni et al.|Cancer Research|2018Cited by 0
Adult “Triple Negative” ACUTE Lymphoblastic Leukemia Genome Wide CharacterizationAnna Ferrari, Giovanni Martinelli, Valentina Robustelli et al.|Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)|2017Cited by 0
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic AberrationGiovanni Marconi, Giovanni Martinelli, Maria Chiara Fontana et al.|Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)|2017Cited by 0